Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1961 1
1964 1
1965 6
1966 2
1967 3
1968 3
1969 1
1970 3
1971 5
1973 2
1974 3
1975 2
1977 3
1978 1
1979 4
1980 2
1981 1
1982 1
1983 1
1985 5
1988 3
1989 3
1990 2
1991 1
1992 2
1993 3
1994 2
1995 2
1996 4
1997 6
1998 4
1999 8
2000 7
2001 7
2002 6
2003 13
2004 2
2005 12
2006 14
2007 11
2008 35
2009 27
2010 24
2011 19
2012 21
2013 22
2014 30
2015 33
2016 21
2017 22
2018 22
2019 32
2020 32
2021 34
2022 23
2023 27
2024 31
2025 21
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

597 results

Results by year

Filters applied: . Clear all
Page 1
Characteristics and quality of life of nine-year survivors with metastatic melanoma treated with pembrolizumab beyond second-line therapy.
Dugas-Breit S, Forschner A, Erdmann M, Gutzmer R, Kähler KC, Holst I, Brekner A, Franklin C, Sindrilaru A, Zimmer L, Heinzerling L, Utikal J, Meier F, Bender A, Berking C, Garbe C, Weichenthal M, Schadendorf D, Hauschild A, Gschnell M, Mohr P, Hassel JC. Dugas-Breit S, et al. Among authors: hauschild a. Eur J Cancer. 2026 Jan 17;233:116149. doi: 10.1016/j.ejca.2025.116149. Epub 2025 Nov 29. Eur J Cancer. 2026. PMID: 41385939 Free article.
Messages for ultraviolet-radiation protection to fair-skinned populations.
Brochez L, Garbe C, Amaral T, Arenberger P, Astratinei V, Autier P, Berwick M, Bylaite M, Boonen B, Del Marmol V, Dreno B, Fargnoli MC, Green AC, Greinert R, Hauschild A, Harwood CA, Hoorens I, Kandolf L, Kaufmann R, Kelleners-Smeets N, Lallas A, Lebbé C, Leiter U, Lim HW, Longo C, Malvehy J, Moreno D, Östman F, Pellacani G, Peris K, Robert C, Ryll B, Saiag P, Schadendorf D, Soyer P, Spurrier-Bernard G, Stockfleth E, Stratigos A, Uhara H, Vieira R, Weinstock MA, Whitaker D, Whiteman DC, Zalaudek I, Forsea AM; EADO Task Force for Prevention and Early Detection of Skin Cancer. Brochez L, et al. Among authors: hauschild a. J Eur Acad Dermatol Venereol. 2025 Nov 6. doi: 10.1111/jdv.70148. Online ahead of print. J Eur Acad Dermatol Venereol. 2025. PMID: 41195957
Baseline D-dimers as predictive marker of efficacy of cemiplimab treatment in cutaneous squamous cell carcinoma.
Geidel G, Adam L, Bänsch S, Fekade N, Degenhardt S, Rünger A, Kött J, Zell T, Heidrich I, Smit DJ, Greinert R, Volkmer B, Pantel K, Mohr P, Hauschild A, Schneider SW, Gebhardt C. Geidel G, et al. Among authors: hauschild a. Eur J Cancer. 2025 Aug 26;226:115639. doi: 10.1016/j.ejca.2025.115639. Epub 2025 Jul 10. Eur J Cancer. 2025. PMID: 40664163 Free article.
Neoadjuvant intralesional targeted immunocytokines (daromun) in stage III melanoma.
Kähler KC, Hassel JC, Ziemer M, Rutkowski P, Meier F, Flatz L, Gaudy-Marqueste C, Zimmer L, Santinami M, Russano F, von Wasielewski I, Eigentler TK, Maio M, Zalaudek I, Haferkamp S, Quaglino P, Welzel J, Röcken C, Enk A, Simon JC, Świtaj T, Garzarolli M, Amaral T, Malissen N, Livingstone E, Elia G, Covelli A, Lorizzo K, Neri D, Mulatto S, Parca A, Pizzichi B, Ascierto PA, Garbe C, Robert C, Schadendorf D, Hauschild A. Kähler KC, et al. Among authors: hauschild a. Ann Oncol. 2025 Oct;36(10):1166-1177. doi: 10.1016/j.annonc.2025.06.014. Epub 2025 Jul 7. Ann Oncol. 2025. PMID: 40633690 Free article. Clinical Trial.
Long-Term Follow-Up of Real-World Adjuvant Anti-PD-1 Checkpoint Inhibition and Targeted Therapy in Patients With Stage III Melanoma.
Lodde GC, Hassel JC, von Wasielewski I, Meier F, Mohr P, Kähler K, Hauschild A, Glutsch V, Stege H, Berking C, Hüning S, Huynh J, Gutzmer R, Reinhardt L, Schilling B, Loquai C, Erdmann M, Stang A, Kowall B, Galetzka W, Roesch A, Tilkorn D, Ugurel S, Zimmer L, Schadendorf D, Forschner A, Livingstone E. Lodde GC, et al. Among authors: hauschild a. J Clin Oncol. 2025 Sep;43(25):2793-2805. doi: 10.1200/JCO-24-02776. Epub 2025 Jun 3. J Clin Oncol. 2025. PMID: 40460331
Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma.
Rischin D, Porceddu S, Day F, Brungs DP, Christie H, Jackson JE, Stein BN, Su YB, Ladwa R, Adams G, Bowyer SE, Otty Z, Yamazaki N, Bossi P, Challapalli A, Hauschild A, Lim AM, Patel VA, Walker JL, De Liz Vassen Schurmann M, Queirolo P, Cañueto J, Ferreira da Silva FA, Stratigos A, Guminski A, Lin C, Damian F, Flatz L, Taylor AE, Carr DR, Harris S, Kirtbaya D, Quereux G, Rutkowski P, Basset-Seguin N, Khushalani NI, Robert C, Ju H, Joseph C, Bansal S, Chen CI, Seebach F, Yoo SY, Lowy I, Goncalves P, Fury MG; C-POST Trial Investigators. Rischin D, et al. Among authors: hauschild a. N Engl J Med. 2025 Aug 21;393(8):774-785. doi: 10.1056/NEJMoa2502449. Epub 2025 May 31. N Engl J Med. 2025. PMID: 40454639 Clinical Trial.
[Adjuvant and neoadjuvant therapy of melanoma].
Debus D, Hauschild A, Schultz ES. Debus D, et al. Among authors: hauschild a. Dtsch Med Wochenschr. 2025 May;150(10):555-561. doi: 10.1055/a-2453-8887. Epub 2025 Apr 22. Dtsch Med Wochenschr. 2025. PMID: 40262754 Review. German.
Clinical validation of droplet digital PCR assays in detecting BRAFV600-mutant circulating tumour DNA as a prognostic biomarker in patients with resected stage III melanoma receiving adjuvant therapy (COMBI-AD): a biomarker analysis from a double-blind, randomised phase 3 trial.
Syeda MM, Long GV, Garrett J, Atkinson V, Santinami M, Schadendorf D, Hauschild A, Millward M, Mandala M, Chiarion-Sileni V, Smylie M, Manikhas GM, Dummer R, Wiggins JM, Ali S, Adnaik SB, Tan M, Dajee M, Polsky D. Syeda MM, et al. Among authors: hauschild a. Lancet Oncol. 2025 May;26(5):641-653. doi: 10.1016/S1470-2045(25)00139-1. Epub 2025 Apr 15. Lancet Oncol. 2025. PMID: 40250457 Clinical Trial.
597 results